Five distinct mechanisms exist, and each has a gate that shuts most people out of most of them. Manufacturer copay assistance, manufacturer patient assistance, manufacturer direct self pay, third party discount cards, and pre tax spending accounts. Insurance status decides which are available, and several of them cannot be used together in one transaction.
Five mechanisms, five different gates
| Mechanism | Run by | Typical eligibility gate | Usable alongside insurance? |
|---|---|---|---|
| Copay assistance card | Drug manufacturer | Commercial insurance required; federal program beneficiaries excluded | Yes, it is designed to sit on top of a claim |
| Patient assistance program | Manufacturer or affiliated foundation | Income tested, often requires being uninsured or underinsured | Usually no, it substitutes for coverage |
| Manufacturer direct self pay | Drug manufacturer | Valid prescription, no claim processed | No, it is a cash channel |
| Discount card rate | Independent card operator | Open to anyone, but rate varies by pharmacy | No, one transaction or the other |
| FSA or HSA funds | Employer or account custodian | Account must exist and be funded | Yes, it changes how the bill is paid |
Why federal coverage closes the copay card door
Copay cards are the single most valuable mechanism for the people who qualify, and the exclusion that surprises people most is that having Medicare, Medicaid, TRICARE, or VA benefits usually disqualifies them. This is not a manufacturer being awkward. Federal anti kickback rules restrict manufacturers from subsidizing cost sharing on prescriptions paid for by federal health programs, so those cards carry an eligibility clause excluding beneficiaries of them.
The practical consequence is that turning 65 and moving onto Medicare can raise out of pocket cost even when nothing about the prescription changes. That is worth planning for a year ahead rather than discovering at a counter.
Discount cards are not insurance, and it shows
GoodRx and SingleCare do not sell medication and do not pay for it. They operate networks of negotiated cash prices at participating pharmacies, and the number shown is what that pharmacy has agreed to accept in a cash transaction. Because it is a cash transaction, it does not run through a plan, does not count toward a deductible, and cannot be stacked on top of a claim in the same purchase.
The useful move is to have the pharmacy price the fill both ways and take whichever is lower, understanding that the card route buys a lower number today at the cost of no progress toward an out of pocket maximum.
The indication on the prescription decides which programs exist
Tirzepatide is sold as two products with different labeled uses. Mounjaro carries an indication for glycemic control in type 2 diabetes. Zepbound carries indications for weight reduction and long term maintenance in adults with obesity or overweight with a related condition, and for moderate to severe obstructive sleep apnea in adults with obesity. Assistance programs are built around a product, not a molecule, so eligibility, terms, and even whether a program exists at all can differ between the two.
Anyone researching savings options should therefore search under the brand name written on the prescription rather than the generic name, and should not assume a term found under one brand applies to the other.
What cash pay practices offer instead
Bundled telehealth practices sit outside this whole system. There is no claim, no card, and no assistance application, because the practice sets its own price for a package of medication and clinical oversight. Henry Meds, Ro, Hims and Hers and FormBlends all work this way. What counts as the eligibility gate is simply whether a clinician judges the prescription appropriate, and the commercial terms are whatever the provider behind it chooses to publish.
Two cautions belong with that. Compounded preparations are not FDA approved, and the agency does not review them for safety, effectiveness, or quality before they are marketed. And federal law allows compounded copies of a marketed drug only under specific statutory conditions, including circumstances tied to the shortage list, so this route rests on rules that are not fixed.
None of that removes the value of a clearly posted price when the assistance routes are closed. Someone paying cash can line up manufacturer options like LillyDirect against monthly telehealth quotes from Ro, Henry Meds, or HealthRX, the last of which publishes its tirzepatide membership rate so the number can be checked against a discount card total at the counter. The gate on those cash routes is a clinician judging the prescription appropriate rather than an insurance rule, which is a different kind of door from the ones above.
The mechanism most people already have and never use
Health savings accounts and flexible spending accounts are the least glamorous item on the list and the one with the widest eligibility. Prescription medication is a qualifying expense, so paying from those funds converts the bill into pre tax dollars. For a recurring monthly cost over a full year, that is a meaningful percentage reduction with no application, no income test, and no interaction with any other mechanism on this page.
The catch is that the account has to be funded through payroll elections that are usually set once a year. Someone starting treatment in March cannot retroactively increase this year’s election in most plans, which makes it a decision to raise during open enrollment rather than at the pharmacy.
Frequently asked questions
Can a manufacturer copay card be used with Medicare?
Generally no. Copay assistance from manufacturers typically excludes beneficiaries of federal health programs, including Medicare, Medicaid, TRICARE, and VA benefits, because federal rules restrict manufacturers from subsidizing cost sharing on federally reimbursed prescriptions. The exclusion is written into the card terms rather than applied case by case.
What is the difference between copay assistance and a patient assistance program?
Copay assistance reduces cost sharing for someone who already has commercial coverage. A patient assistance program supplies medication to people who cannot obtain it otherwise, and is typically income tested with documentation requirements. They serve opposite situations, which is why almost nobody qualifies for both at once.
Does a discount card count toward a deductible?
No. A card rate is a cash purchase at a contracted price, so no claim reaches the plan and nothing is credited toward a deductible or an out of pocket maximum. For someone likely to hit that maximum during the year, the lower cash price today can be the more expensive choice overall.
Do savings programs cover compounded versions?
No. Manufacturer copay cards, patient assistance programs, and manufacturer direct pricing all attach to specific approved products. Compounded preparations are outside that system entirely, which is why practices offering them quote a flat price rather than pointing at an assistance program.
Which mechanism is worth checking first?
Start with insurance status, because it determines the shortlist. Commercial coverage opens copay assistance. Federal coverage closes it and makes the plan formulary the main lever. No coverage points toward manufacturer direct pricing, discount card rates, and patient assistance, in that order of effort.
